Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: Lessons learned from trials and treatment studies

American Journal of Preventive Medicine

Volumn 44, Issue 1 SUPPL. 2, 2013, Pages

  Koenig, Linda J ^a   Lyles, Cynthia ^a   Smith, Dawn K ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANUS INTERCOURSE; ARTICLE; ATTITUDE TO HEALTH; DECISION MAKING; DOCTOR PATIENT RELATION; DRUG INFORMATION; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SATISFACTION; PRE EXPOSURE PROPHYLAXIS; PUBLIC HEALTH; QUALITY OF LIFE; RISK FACTOR; RISK REDUCTION; SELF REPORT; SEXUAL BEHAVIOR; SOCIAL ASPECT; SOCIAL SUPPORT;

EID: 84871777801     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2012.09.047     Document Type: Review

References (76)

1. J.D. Campbell, J.H. Herbst, R.T. Koppenhaver, D.K. Smith Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV Am J Prev Med 44 1S2 2013 S63 S69
2. L. Van Damme, A. Corneli, K. Ahmed Preexposure prophylaxis for HIV infection among African women N Engl J Med 367 5 2012 411 422
3. R.M. Grant, J.R. Lama, P.L. Anderson Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 27 2010 2587 2599
4. J. Baeten, D. Donnell, P. Ndase Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 5 2012 399 410
5. M.C. Thigpen, P.M. Kebaabetswe, L.A. Paxton Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana N Engl J Med 367 5 2012 423 434
6. Food and Drug Administration Background package for NDA 21-752/Supplement 30 2011
7. Gilead Sciences. Gilead presentations. Proceedings of the Meeting of the Antiviral Drugs Advisory Committee; 2012 May 10.
8. Bangsberg D, Haberer JE, Psaros C, et al. High adherence and high effectiveness observed in HIV disordant couples: Partners PrEP study, adherence monitoring and counseling substudy. Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections; 2012; Seattle WA.
9. Donnell D, Baeten J, Hendrix C, et al. Session 30 Webcast: Tenofovir disoproxil fumarate drug levels indicate PrEP use is strongly correlated with HIV-1 protective effects: Kenya and Uganda. Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections; 2012; Seattle WA.
10. N.C. Ware, M.A. Wyatt, J.E. Haberer What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples J Acquir Immune Defic Syndr 59 5 2012 463 468
11. Haberer J, Baeten J, Celum C, et al. High adherence among HIV-1 serodiscordant couples in the partners PrEP Ancillary Adherence Study. Proceedings of the 7th International Conference on HIV Treatment and Prevention Adherence; 2012; Miami FL.
12. C. Ortego, T.B. Huedo-Medina, J. Llorca Adherence to highly active antiretroviral therapy (HAART): a meta-analysis AIDS Behav 15 7 2011 1381 1396
13. S.L. Reisner, M.J. Mimiaga, M. Skeer, B. Perkovich, C.V. Johnson, S.A. Safren A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth Top HIV Med 17 1 2009 14 25
14. M.A. Chesney Factors affecting adherence to antiretroviral therapy Clin Infect Dis 30 S2 2000 S171 S176
15. M. Kyser, K. Buchacz, T.J. Bush Factors associated with non-adherence to antiretroviral therapy in the SUN study AIDS Care 23 5 2011 601 611
16. P.S. Sullivan, M.L. Campsmith, G.V. Nakamura, E.B. Begley, J. Schulden, A.K. Nakashima Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy PLoS One 2 6 2007 e552
17. J.A. Bartlett Addressing the challenges of adherence J Acquir Immune Defic Syndr 29 S1 2002 S2 S10
18. S. Mannheimer, G. Friedland, J. Matts, C. Child, M. Chesney The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials Clin Infect Dis 34 8 2002 1115 1121
19. J.B. Nachega, C. Morroni, J.M. Zuniga HIV treatment adherence, patient health literacy, and health care provider-patient communication: results from the 2010 AIDS Treatment for Life International Survey J Int Assoc Physicians AIDS Care 11 2 2012 128 133
20. L. Weiss, T. French, M. Waters, J. Netherland, B. Agins, R. Finkelstein Adherence to HAART: perspectives from clients in treatment support programs Psychol Health Med 11 2 2006 155 170
21. A. Ammassari, M.P. Trotta, R. Murri Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature J Acquir Immune Defic Syndr 31 S3 2002 S123 S127
22. M.J. Atkinson, J.J. Petrozzino An evidence-based review of treatment-related determinants of patients' nonadherence to HIV medications AIDS Patient Care STDS 23 11 2009 903 914
23. M.M. Azar, S.A. Springer, J.P. Meyer, F.L. Altice A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization Drug Alcohol Depend 112 3 2010 178 193
24. J.W. Bae, W. Guyer, K. Grimm, F.L. Altice Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research AIDS 25 3 2011 279 290
25. L. Fogarty, D. Roter, S. Larson, J. Burke, J. Gillespie, R. Levy Patient adherence to HIV medication regimens: a review of published and abstract reports Patient Educ Couns 46 2 2002 93 108
26. V.A. Gruber, J.L. Sorensen, N.A. Haug Psychosocial predictors of adherence to highly active antiretroviral therapy J HIV AIDS Soc Serv 6 1-2 2007 23 37
27. M. Malta, S.A. Strathdee, M.M. Magnanini, F.I. Bastos Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review Addiction 103 8 2008 1242 1257
28. M. Malta, M.M. Magnanini, S.A. Strathdee, F.I. Bastos Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis AIDS Behav 14 4 2010 731 747
29. E.J. Mills, J.B. Nachega, D.R. Bangsberg Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators PLoS Med 3 11 2006 e438
30. J.J. Parienti, D.R. Bangsberg, R. Verdon, E.M. Gardner Better adherence with once-daily antiretroviral regimens: a meta-analysis Clin Infect Dis 48 4 2009 484 488
31. M. Sandelowski, C.I. Voils, Y. Chang, E.J. Lee A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the U.S. AIDS Care 21 8 2009 953 966
32. J.M. Simoni, A. Montgomery, E. Martin, M. New, P.A. Demas, S. Rana Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management Pediatrics 119 6 2007 e1371 e1383
33. R.G. Steele, D. Grauer Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research Clin Child Fam Psychol Rev 6 1 2003 17 30
34. A.K. Wutoh, O. Elekwachi, V. Clarke-Tasker, M. Daftary, N.J. Powell, G. Campusano Assessment and predictors of antiretroviral adherence in older HIV-infected patients J Acquir Immune Defic Syndr 33 S2 2003 S106 S114
35. L.R. Beer, E. Frazier, C. Mattson, E. Valverde, A. Do Adherence to antiretroviral medications in a national sample of HIV-infected patients in care in the U.S. 2010; Vacouver, BC idsa.confex.com/idsa/2010/webprogram/Paper2673. html
36. A.A. Howard, J.H. Arnsten, Y. Lo A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women AIDS 16 16 2002 2175 2182
37. D.L. Paterson, S. Swindells, J. Mohr Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 1 2000 21 30
38. J.M. Duggan, A. Locher, B. Fink, C. Okonta, J. Chakraborty Adherence to antiretroviral therapy: a survey of factors associated with medication usage AIDS Care 21 9 2009 1141 1147
39. J.K. Côté, G. Godin Efficacy of interventions in improving adherence to antiretroviral therapy Int J STD AIDS 16 5 2005 335 343
40. J.M. Simoni, P.A. Frick, D.W. Pantalone, B.J. Turner Antiretroviral adherence interventions: a review of current literature and ongoing studies Top HIV Med 11 6 2003 185 198
41. K.R. Amico, J.J. Harman, B.T. Johnson Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004 J Acquir Immune Defic Syndr 41 3 2006 285 297
42. J.E. Hart, C.Y. Jeon, L.C. Ivers Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review J Acquir Immune Defic Syndr 54 2 2010 167 179
43. S. Rueda, L.Y. Park-Wyllie, A.M. Bayoumi Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS Cochrane Database Syst Rev 3 2006 CD001442
44. J.M. Simoni, C.R. Pearson, D.W. Pantalone, G. Marks, N. Crepaz Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load A meta-analytic review of randomized controlled trials J Acquir Immune Defic Syndr 43 S1 2006 S23 S35
45. J.M. Simoni, K.R. Amico, L. Smith, K. Nelson Antiretroviral adherence interventions: translating research findings to the real world clinic Curr HIV/AIDS Rep 7 1 2010 44 51
46. J. Wise, D. Operario Use of electronic reminder devices to improve adherence to antiretroviral therapy: a systematic review AIDS Patient Care STDS 22 6 2008 495 504
47. F.L. Altice, D.S. Maru, R.D. Bruce, S.A. Springer, G.H. Friedland Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial Clin Infect Dis 45 6 2007 770 778
48. L.J. Koenig, S.L. Pals, T. Bush, P.M. Palmore, D. Stratford, T.V. Ellerbrock Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy Health Psychol 27 2 2008 159 169
49. G.M. Lucas, B.A. Mullen, P.J. Weidle, S. Hader, M.E. McCaul, R.D. Moore Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups Clin Infect Dis 42 11 2006 1628 1635
50. J. Milam, J.L. Richardson, A. McCutchan Effect of a brief antiretroviral adherence intervention delivered by HIV care providers J Acquir Immune Defic Syndr 40 3 2005 356 363
51. R.H. Remien, M.J. Stirratt, C. Dolezal Couple-focused support to improve HIV medication adherence: a randomized controlled trial AIDS 19 8 2005 807 814
52. J.M. Simoni, D. Huh, P.A. Frick Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial J Acquir Immune Defic Syndr 52 4 2009 465 473
53. A.B. Williams, K.P. Fennie, C.A. Bova, J.D. Burgess, K.A. Danvers, K.D. Dieckhaus Home visits to improve adherence to highly active antiretroviral therapy: a randomized controlled trial J Acquir Immune Defic Syndr 42 3 2006 314 321
54. M.K. ElZarrad, E.T. Eckstein, R.E. Glasgow Applying chronic illness care, implementation science, and self-management support to HIV Am J Prev Med 44 1S2 2013 S99 S107
55. L. Osterberg, T. Blaschke Adherence to medication N Engl J Med 353 5 2005 487 497
56. P.M. Ho, C.L. Bryson, J.S. Rumsfeld Medication adherence Circulation 119 23 2009 3028 3035
57. D.M. Cutler, W. Everett Thinking outside the pillbox - medication adherence as a priority for health care reform N Engl J Med 362 17 2010 1553 1555
58. D.K. Smith, L. Toledo, D.J. Smith, M.A. Adams, R. Rothenberg Attitudes and program preferences of African American urban young adults about pre-exposure prophylaxis (PrEP) AIDS Educ Prev 24 5 2012 408 421
59. Gilead Sciences Important safety information about TRUVADA for a pre-exposure prophylaxis (PrEP) indication for uninfected individuals 2012
60. CDC Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men MMWR Morb Mortal Wkly Rep 60 3 2011 65 68
61. CDC Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults MMWR Morb Mortal Wkly Rep 61 31 2012 586 590
62. Susan's Simple Solutions Blog Eight apps to help improve medication adherence. 2011 www.susanssimplesolutions.com/eight-apps-to-help-improve- medication-adherence/
63. C. Gullo AMA offers medication adherence app for patients MobiHealth News 2011
64. G.W. Ryan, G.J. Wagner Pill taking "routinization": a critical factor to understanding episodic medication adherence AIDS Care 15 6 2003 795 806
65. J. Wrubel, S. Stumbo, M.O. Johnson Antiretroviral medication support practices among partners of men who have sex with men a qualitative study AIDS Patient Care and STDs 22 11 2008 851 858
66. A.G. Crawford, V. Sikirica, N. Goldfarb Interactive voice response reminder effects on preventive service utilization Am J Med Qual 20 6 2005 329 336
67. M. Vervloet, A.J. Linn, J.C.M. van Weert, D.H. de Bakker, M.L. Bouvy, L. van Dijk The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature J Am Med Inform Assoc 19 5 2012 696 704
68. N. El-Bassel, R.H. Remien Couple-based HIV prevention and treatment: state of science, gaps, and future directions W. Pequegnat, C.C. Bell, Family and HIV/AIDS 2012 Springer New York 153 172
69. Substance Abuse and Mental Health Serivces Administration Screening, Brief Intervention, and Referral to Treatment (SBIRT) www.samhsa.gov/prevention/ sbirt/ 2012
70. Substance Abuse and Mental Health Services Administration White paper: Screening, Brief Intervention and Referral to Treatment (SBIRT) in behavioral healthcare 2011
71. B.J. Anderson, J. Brackett, J. Ho, L.M. Laffel An office-based intervention to maintain parent-adolescent teamwork in diabetes management Impact on parent involvement, family conflict, and subsequent glycemic control Diabetes Care 22 5 1999 713 721
72. S. Golub, D. Operario, P. Gorbach Pre-exposure prophylaxis state of the science: empirical analogies for research and implementation Curr HIV/AIDS Rep 7 4 2010 201 209
73. M. Stirratt, C. Gordon Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research Curr HIV/AIDS Rep 5 4 2008 186 192
74. K.S.H. Yarnall, K.I. Pollak, T. Østbye, K.M. Krause, J.L. Michener Primary care: is there enough time for prevention? Am J Public Health 93 4 2003 635 641
75. J.D. Hirsch, M. Gonzales, A. Rosenquist, T.A. Miller, T.P. Gilmer, B.M. Best Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS J Managed Care Pharm 17 3 2011 213 223
76. G.M. Kuo, T.E. Buckley, D.S. Fitzsimmons, J.R. Steinbauer Collaborative drug therapy management services and reimbursement in a family medicine clinic Am J Health Syst Pharm 61 4 2004 343 354